Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares Repurchased
Ratios

Corcept Therapeutics (CORT) Shares Repurchased (2018 - 2025)

Corcept Therapeutics' Shares Repurchased history spans 6 years, with the latest figure at $42.5 million for Q3 2025.

  • For Q3 2025, Shares Repurchased rose 262.63% year-over-year to $42.5 million; the TTM value through Dec 2025 reached $172.9 million, up 1003.9%, while the annual FY2025 figure was $172.9 million, 1003.9% up from the prior year.
  • Shares Repurchased for Q3 2025 was $42.5 million at Corcept Therapeutics, down from $103.0 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $119.0 million in Q4 2021 and bottomed at $476000.0 in Q1 2024.
  • The 3-year median for Shares Repurchased is $28.3 million (2021), against an average of $39.6 million.
  • The largest annual shift saw Shares Repurchased surged 43378.18% in 2021 before it skyrocketed 262.63% in 2025.
  • A 3-year view of Shares Repurchased shows it stood at $119.0 million in 2021, then tumbled by 90.16% to $11.7 million in 2024, then surged by 262.63% to $42.5 million in 2025.
  • Per Business Quant, the three most recent readings for CORT's Shares Repurchased are $42.5 million (Q3 2025), $103.0 million (Q2 2025), and $27.4 million (Q1 2025).